evodiamine has been researched along with Stomach Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Lei, F; Li, J; Liang, Z; Shi, T; Wang, Y; Wang, Z; Yang, X; Zhang, H | 1 |
| Ge, K; Guo, Y; Li, P; Liu, L; Zhang, H | 1 |
| Guan, W; Liu, B; Qian, X; Shen, J; Wang, H; Wei, J; Yu, L; Yue, G; Zou, Z | 1 |
| Liu, Y; Shi, HL; Wu, XJ; Xie, JQ | 1 |
| Bi, Y; Huang, H; Liu, X; Ran, G; Wu, D; Yang, L; Zhang, M | 1 |
| Feng, S; Hong, D; Wang, Q; Wang, Z; Wei, L; Wen, Z | 1 |
| Bi, Y; Huang, H; Liu, X; Wang, LH; Yang, L | 1 |
| Gao, X; Guo, Q; Han, Y; Hu, C; Liu, M; Wang, J; Wang, Y; Zhang, K | 1 |
| He, S; Huang, H; Huang, Y; Li, Z; Liu, X; Xu, W; Zhang, H; Zhang, Y | 1 |
| Khan, M; Ma, T; Rasul, A; Yang, H; Yu, B; Zhong, L | 1 |
10 other study(ies) available for evodiamine and Stomach Neoplasms
| Article | Year |
|---|---|
Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Quinazolines; Stomach Neoplasms; Structure-Activity Relationship | 2022 |
Effect of evodiamine on cell death pathways in human gastric cancer cells.
Topics: Apoptosis; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; Reactive Oxygen Species; Stomach Neoplasms | 2022 |
Synergistic anticancer effects of polyphyllin I and evodiamine on freshly-removed human gastric tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Confidence Intervals; Diosgenin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Irinotecan; Male; Middle Aged; Neoplasm Proteins; Platinum; Quinazolines; RNA, Messenger; Stomach Neoplasms | 2013 |
Berberine counteracts enhanced IL-8 expression of AGS cells induced by evodiamine.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Chemokines; Chemokines, CXC; Chromones; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-8; Morpholines; Pyridines; Quinazolines; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2013 |
Growth inhibition and induction of apoptosis in SGC‑7901 human gastric cancer cells by evodiamine.
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Shape; Humans; Quinazolines; Stomach Neoplasms | 2014 |
Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; beta Catenin; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Epithelial-Mesenchymal Transition; Flow Cytometry; Humans; Kruppel-Like Factor 4; Molecular Structure; Neoplastic Stem Cells; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Quinazolines; Snail Family Transcription Factors; Stomach Neoplasms; Transcription Factors; Twist-Related Protein 1; Wnt Signaling Pathway | 2015 |
[Effect of evodiamine in inducing apoptosis of gastric cancer SGC-7901 cells through mTOR signal pathway].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drugs, Chinese Herbal; Humans; Quinazolines; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases | 2015 |
Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy in vitro and in vivo.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Immunohistochemistry; Male; Mice; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Radiation-Sensitizing Agents; Receptor, ErbB-2; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Acid sphingomyelinase contributes to evodiamine-induced apoptosis in human gastric cancer SGC-7901 cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Ceramides; Chromatography, High Pressure Liquid; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Plant Extracts; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Stomach Neoplasms; Up-Regulation | 2011 |
Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; bcl-2-Associated X Protein; Beclin-1; Cell Cycle; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Stomach Neoplasms | 2012 |